slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 28,531-28,560
Pages 1,418
Rows per page 30
Beat
28,531-28,560 of 42,534
20
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
21
The slide outlines the core assets (nemvaleukin alfa, IL-12, IL-18) and the strategic rationale for a spin-off.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses a human body diagram to map clinical responses (CR, PR, uPR) by tumor type.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
23
The slide uses a 2x2 matrix-like layout to categorize studies by 'Potential Registration Enabling Studies' and 'Alternative Dosing Studies'.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
24
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
25
The slide outlines the strategic rationale for a corporate spin-off, focusing on the remaining neuroscience-focused entity.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
26
The chart tracks revenue for VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
27
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
28
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
15
The chart highlights the stability of share counts over time, supporting the goal of managing dilution.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
16
Amazon | Results Presentation Deck | 19 slidesAmazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
17
The table displays financial data in millions (MM).Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
18
The table displays TTM (Trailing Twelve Months) data points for five consecutive quarters from Q4 2021 to Q4 2022.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
19
The table provides a detailed breakdown of cash flow adjustments for finance leases and financing obligations.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
15
The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Before After1 hit
16
The slide uses immunofluorescence microscopy to show structural damage and bar charts/traces to show functional respiratory recovery.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
17
Includes a biological mechanism diagram on the left and a clinical trial design timeline/process on the right.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
18
The slide uses a series of four circular icons atop vertical color-coded columns to categorize medical indications by therapeutic area.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
19
The slide uses a hub-and-spoke style layout to show relationships between entities.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
20
The slide uses a dual-section layout separating commercial and clinical activities, with specific dates aligned to each milestone.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
21
The diagram features five core values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
22
The chart uses a horizontal bar format to represent clinical trial progress from Preclinical to Commercial stages.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
17
Babylon | Investor Conference Presentation Deck | 19 slidesBabylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · Resolution1 hit
16
The chart uses a segmented bar approach to compare established industry players against BenevolentAI's projected output.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
17
The slide uses a hub-and-spoke style diagram to show how a central platform feeds into four different commercialization strategies.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
18
The chart uses a timeline-like structure to show drug development stages from Target ID to Phase II.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a two-column layout to contrast the disease burden (left) with the proposed therapeutic solution (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
20
Includes specific caveats regarding study power and dosing duration.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
21
The slide uses a split-column layout to contrast the disease burden/market need (left) with the proposed solution/mechanism (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses a process diagram to show the experimental workflow (biopsy to culture to measurement) followed by bar charts showing cytokine reduction.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit